| 135.52 Delayed Data As of Sep 20 |  +2.57 / +1.93%Today’s Change | 105.19 Today|||52-Week Range 179.57 | -3.38% Year-to-Date |
| Previous close | 132.95 |
| Today’s open | 132.46 |
| Day’s range | 132.03 - 137.86 |
| Volume | 423,599 |
| Average volume (3 months) | 293,737 |
| Market cap | $8.2B |
| Earnings growth (last year) | -670.85% |
| Earnings growth (this year) | +6.16% |
| Earnings growth (next 5 years) | +24.00% |
| Revenue growth (last year) | -17.21% |
| P/E ratio | NM |
| Price/Sales | 39.27 |
| Price/Book | 4.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | -0.08 | -1.06% |
| BBIOBridgeBio Pharma Inc | +1.74 | +7.09% |
| AKRXAkorn Inc | +0.43 | +11.72% |
| Next reporting date | November 11, 2019 |
| EPS forecast (this quarter) | -$3.76 |
| Annual revenue (last year) | $198.0M |
| Annual profit (last year) | -$673.2M |
| Net profit margin | -339.91% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer John V. Oyler |
President & General Manager-China Region Xiao Bin Wu |
Corporate headquarters Beijing, Beijing |
